476060.KQ
Onconic Therapeutics
KOE · Healthcare · Biotechnology · KR
KRW 17,110.00
+1.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.14x
- P/E 2027E
- 3.39x
- P/E 2028E
- —
- P/S forward
- 11.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.48x
- PEG TTM
- —
- Price / book
- 8.95x
- Price / sales
- 9.34x
- Price / cash flow
- 45.68x
Enterprise value
- Enterprise value
- KRW 705.4B
- EV / sales
- 8.58x
- EV / EBITDA
- 37.21x
- EV / EBIT
- 40.77x
- Market cap
- KRW 767.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026